RxDoctor Payments Data

Jocile Hubenthal

Surgical · New Orleans, LANPI 1972953271

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $676 and has fallen 72.5% since, to $186 in 2025.

$1,904in general payments, 2019–2025

Across 33 payments — averaging $57.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$419
  • Gilead$227
  • CSL Behring$221
  • Inari Medical, Inc.$188
  • Vertex$150
  • Sanofi$125
  • plus $574 from 11 others

What the payments were for

  • Food & beverage$1,904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,904 in reported general payments places this provider in the 75th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$1,081
Medicare patients
15
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen209$8,605
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen119$4,869
Oxycodone Hcl63$829
Cyclobenzaprine Hcl70$658
Lidocaine11$563
Pregabalin23$524
Gabapentin60$513
Diclofenac Sodium11$362
Celecoxib32$341
Tizanidine Hcl44$305
Methocarbamol28$303
Diazepam36$271
Nabumetone25$243
Ibuprofen12$150
Alprazolam18$125

Paid to pharmacies, not to this prescriber.

Other surgical in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →